Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15


Methylsulfonylmethane (MSM): A chemical shift reference for 1 H MRS of human brain.

Kaiser LG, Russell D, Maschmeyer T, Redfern RL, Inglis BA.

Magn Reson Med. 2019 Sep 30. doi: 10.1002/mrm.27997. [Epub ahead of print]


Neutrophils cause obstruction of eyelid sebaceous glands in inflammatory eye disease in mice.

Reyes NJ, Yu C, Mathew R, Kunnen CM, Kalnitsky J, Redfern RL, Leonardi A, Perez VL, MacLeod AS, Gupta PK, Saban DR.

Sci Transl Med. 2018 Jul 25;10(451). pii: eaas9164. doi: 10.1126/scitranslmed.aas9164.


MyD88 Deficiency Protects Against Dry Eye-Induced Damage.

Reins RY, Lema C, Courson J, Kunnen CME, Redfern RL.

Invest Ophthalmol Vis Sci. 2018 Jun 1;59(7):2967-2976. doi: 10.1167/iovs.17-23397.


High-Mobility Group Box 1 in Dry Eye Inflammation.

Lema C, Reins RY, Redfern RL.

Invest Ophthalmol Vis Sci. 2018 Apr 1;59(5):1741-1750. doi: 10.1167/iovs.17-23363.


MyD88 contribution to ocular surface homeostasis.

Reins RY, Courson J, Lema C, Redfern RL.

PLoS One. 2017 Aug 10;12(8):e0182153. doi: 10.1371/journal.pone.0182153. eCollection 2017.


Analysis of tear inflammatory mediators: A comparison between the microarray and Luminex methods.

Dionne K, Redfern RL, Nichols JJ, Nichols KK.

Mol Vis. 2016 Feb 23;22:177-88. eCollection 2016.


Dry eye modulates the expression of toll-like receptors on the ocular surface.

Redfern RL, Barabino S, Baxter J, Lema C, McDermott AM.

Exp Eye Res. 2015 May;134:80-9. doi: 10.1016/j.exer.2015.03.018. Epub 2015 Mar 25.


The TFOS International Workshop on Contact Lens Discomfort: report of the definition and classification subcommittee.

Nichols KK, Redfern RL, Jacob JT, Nelson JD, Fonn D, Forstot SL, Huang JF, Holden BA, Nichols JJ; members of the TFOS International Workshop on Contact Lens Discomfort.

Invest Ophthalmol Vis Sci. 2013 Oct 18;54(11):TFOS14-9. doi: 10.1167/iovs.13-13074. No abstract available.


Dry eye disease and microbial keratitis: is there a connection?

Narayanan S, Redfern RL, Miller WL, Nichols KK, McDermott AM.

Ocul Surf. 2013 Apr;11(2):75-92. doi: 10.1016/j.jtos.2012.12.002. Epub 2013 Jan 29. Review.


Toll-like receptor expression and activation in mice with experimental dry eye.

Redfern RL, Patel N, Hanlon S, Farley W, Gondo M, Pflugfelder SC, McDermott AM.

Invest Ophthalmol Vis Sci. 2013 Feb 28;54(2):1554-63. doi: 10.1167/iovs.12-10739.


Toll-like receptor activation modulates antimicrobial peptide expression by ocular surface cells.

Redfern RL, Reins RY, McDermott AM.

Exp Eye Res. 2011 Mar;92(3):209-20. doi: 10.1016/j.exer.2010.12.005. Epub 2010 Dec 31.


Toll-like receptors in ocular surface disease.

Redfern RL, McDermott AM.

Exp Eye Res. 2010 Jun;90(6):679-87. doi: 10.1016/j.exer.2010.03.012. Epub 2010 Mar 24. Review.


In vitro activity of human beta-defensin 2 against Pseudomonas aeruginosa in the presence of tear fluid.

Huang LC, Redfern RL, Narayanan S, Reins RY, McDermott AM.

Antimicrob Agents Chemother. 2007 Nov;51(11):3853-60. Epub 2007 Aug 27.


Defensin expression by the cornea: multiple signalling pathways mediate IL-1beta stimulation of hBD-2 expression by human corneal epithelial cells.

McDermott AM, Redfern RL, Zhang B, Pei Y, Huang L, Proske RJ.

Invest Ophthalmol Vis Sci. 2003 May;44(5):1859-65.


Human beta-defensin 2 is up-regulated during re-epithelialization of the cornea.

McDermott AM, Redfern RL, Zhang B.

Curr Eye Res. 2001 Jan;22(1):64-7.


Supplemental Content

Loading ...
Support Center